Abstract:In humans, intestinal defences develop during gestation and, at full term, have the capacity to respond in an appropriate manner to infectious agents and foreign antigens. Before an active protective response can occur, however, the gut must first be exposed to colonizing bacteria. Colonization with diverse intestinal microbes is necessary for the development of important gut defenses such as the synthesis and secretion of polymeric immunoglobulin A and the generation of a balanced T helper (Th) cell response. Insights into normal immune physiological development of the gut have been made by studying the germ-free animal and intestinal defenses. These studies have provided insights into the physiology of immune responses. Two important immunological functions are the secretion of polymeric immunoglobulin A to protect the intestinal surface against harmful stimuli and inhibition of the systemic response to commensal bacteria and food proteins (eg, oral tolerance) to prevent chronic inflammation. Neither function exists in the germ-free state, but rapidly develops after conventionalization (colonization) of the germ-free animal. In the present review, the importance of bacterial colonization on the appearance of normal mucosal immune function and to the clinical consequences of inadequate colonization to the development of disease will be discussed. For example, excessive Th2 activity can lead to atopy, whereas Th1 predominance is found in conditions such as Helicobacter pylori gastritis and Crohn's disease. With the eradication of infectious diseases in developed countries in the past three decades, the incidence of atopic and autoimmune diseases has increased. This epidemiological observation has been explained by the 'hygiene hypothesis', which suggests that a reduction in microbial burden by public health measures has contributed to an immunological imbalance in the intestine. A family of pattern recognition receptors (Toll-like receptors) on gut lymphoid and epithelial cells mediates innate immune responses to bacterial molecular patterns and, thereby, orchestrates acquired immunity. As the role of bacterial communication within the gut (bacterial-epithelial cross-talk) is clarified, physicians should be able to modulate gut immune responses, for example, by the use of probiotics.

Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes

Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene

The “Microflora Hypothesis” of Allergic Disease

Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease

The possible mechanisms of the human microbiome in allergic diseases

Pathogenesis of Children’s Allergic Diseases: Refocusing the Role of the Gut Microbiota

The hygiene hypothesis in autoimmunity: the role of pathogens and commensals

Microbiome Composition and Its Impact on the Development of Allergic Diseases

Defining dysbiosis and its influence on host immunity and disease

The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases

[Microbiota in food allergy: prebiotics, probiotics and synbiotics]

The nutrition-gut microbiome-physiology axis and allergic diseases

Influence and effect of the human microbiome in allergy and asthma

Protective and Stochastic Correlation Between Infectious Diseases and Autoimmune Disorders

The influence of modern living conditions on the human microbiome and potential therapeutic opportunities for allergy prevention

The Role of Early Life Microbiota Composition in the Development of Allergic Diseases

Bacteria and Allergic Diseases

Microbial intestinal dysbiosis drives long-term allergic susceptibility by sculpting an ILC2-B1 cell-innate IgE axis

Development of systemic and mucosal immune responses against gut microbiota in early life and implications for the onset of allergies

Bacterial colonization and the development of intestinal defences

Microbial dysbiosis in the gut drives systemic autoimmune diseases